'Mind Blowing' Results in Teen Weight-Loss Trial

(MedPage Today) -- SAN DIEGO -- In addition to lifestyle intervention, taking 2.4-mg semaglutide (Wegovy) once a week led to greater reductions in body mass index (BMI) and body weight for adolescents with obesity, a phase IIIa randomized trial...
Source: MedPage Today Primary Care - Category: Primary Care Source Type: news